Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Generalized Anxiety Disorder

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Clinical Site, Birmingham, Alabama, United States

  • Clinical Site, Little Rock, Arkansas, United States

  • Clinical Site, Rogers, Arkansas, United States

  • Clinical Site, Culver City, California, United States

  • Clinical Site_2, Encino, California, United States

  • Clinical Site, Encino, California, United States

  • Clinical Site, Los Angeles, California, United States

  • Clinical Site, Oceanside, California, United States

  • Clinical Site, Sherman Oaks, California, United States

  • Clinical Site, Upland, California, United States

  • Clinical Site, Walnut Creek, California, United States

  • Clinical Site, Farmington, Connecticut, United States

  • Clinical Site, Gainesville, Florida, United States

  • Clinical Site, Miami, Florida, United States

  • Cinical Site, Orlando, Florida, United States

  • Clinical Site, Tampa, Florida, United States

  • Clinical Site, Tampa, Florida, United States

  • Clinical Site, Decatur, Georgia, United States

  • Clinical Site, Chicago, Illinois, United States

  • Clinical Site, Boston, Massachusetts, United States

  • Clinical Site, Flowood, Mississippi, United States

  • Clinical Site, Brooklyn, New York, United States

  • Clinical Site, Buffalo, New York, United States

  • Clinical Site, Staten Island, New York, United States

  • Clinical Site, Columbus, Ohio, United States

  • Clinical Site, Oklahoma City, Oklahoma, United States

  • Clinical Site, Media, Pennsylvania, United States

  • Clinical Site, Dallas, Texas, United States

  • Clinical Site, Dallas, Texas, United States

  • Clinical Site, Bellevue, Washington, United States

  • Clinical Site, Blagoevgrad, Bulgaria

  • Clinical Site, Kardzhali, Bulgaria

  • Clinical Site, Pleven, Bulgaria

  • Clinical Site, Plovdiv, Bulgaria

  • Clinical Site, Rousse, Bulgaria

  • Clinical Site, Sofia, Bulgaria

  • Clinical Site, Sofia, Bulgaria

  • Clinical Site, Sofia, Bulgaria

  • Clinical Site, Targovishte, Bulgaria

  • Clinical Site, Helsinki, Finland

  • Clinical Site, Kuopio, Finland

  • Clinical Site, Oulu, Finland

  • Clinical Site, Tampere, Finland

  • Clinical Site, Bialystok, Poland

  • Clinical Site, Bydgoszcz, Poland

  • Clinical Site, Gdansk, Poland

  • Clinical Site, Leszno, Poland

  • Clinical Site, Torun, Poland

  • Clinical Site_2, Belgrade, Serbia

  • Clinical Site_3, Belgrade, Serbia

  • Clinical Site_4, Belgrade, Serbia

  • Clinical Site, Belgrade, Serbia

  • Clinical Site, Kovin, Serbia

  • Clinical Site, Kragujevac, Serbia

  • Clinical Site, Niš, Serbia

  • Clinical Site, Novi Kneževac, Serbia

  • Clinical Site, Bratislava, Slovakia

  • Clinical Site, Rimavská Sobota, Slovakia

  • Clinical Site, Svidník, Slovakia

  • Clinical Site, Vranov nad Topľou, Slovakia